These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 5955738)

  • 1. [Experimental study of the disappearance rate of plasma heparin after an intravenous injection].
    Weiss M
    Hemostase; 1966; 6(2):149-66. PubMed ID: 5955738
    [No Abstract]   [Full Text] [Related]  

  • 2. Improved survival rates in dogs after extracorporeal circulation by improved control of heparin levels.
    Akkerman JW; Runne WC; Sixma JJ; Zimmerman AN
    J Thorac Cardiovasc Surg; 1974 Jul; 68(1):59-65. PubMed ID: 4834066
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of multiple intravenous injections of heparin on the content of antithrombin III in healthy animals and experimental atherosclerosis].
    Kudriashov BA; Pastorova VE; Bazaz'ian GG; Liapina LA
    Vopr Med Khim; 1984; 30(1):82-6. PubMed ID: 6710943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Micromethod for the determination of heparin in plasma after intravenous and subcutaneous administration.
    Oreste P; Peruzzi M; Stella P
    Anal Biochem; 1993 Apr; 210(1):136-9. PubMed ID: 8489009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacokinetics of an unfractionated heparin (Liquemin) in the dog after intravenous and subcutaneous application based on heparin activity].
    Jacobs C; Grebe S; Kietzmann M; Mischke R
    Dtsch Tierarztl Wochenschr; 1999 Nov; 106(11):478-81. PubMed ID: 10609418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of protamine of the prolonged response to intrapulmonary heparin.
    Wright CJ; Mahadoo J; Jaques LB
    Can J Surg; 1981 Mar; 24(2):130-2. PubMed ID: 7225967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Appearance of heparin antithrombin-active chains in vivo after injection of commercial heparin and in anaphylaxis.
    Levy SW; Jaques LB
    Thromb Res; 1978 Sep; 13(3):429-41. PubMed ID: 741437
    [No Abstract]   [Full Text] [Related]  

  • 8. Quantitative heparin determination and periodic extracorporeal dialysis.
    Thurnherr N; Thölen H; Duckert F
    Helv Med Acta; 1967 Jan; 33(4):334-43. PubMed ID: 6062925
    [No Abstract]   [Full Text] [Related]  

  • 9. Characterization of a new potent heparin. 6th communication: The comparison of the anticoagulant effect of the sodium and calcium salts of a new potent heparin after s.c. injection in beagle dogs.
    Bhargava AS; Schöbel C; Günzel P
    Arzneimittelforschung; 1981; 31(1):79-82. PubMed ID: 7194097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulation of lecithin:cholesterol acyl transfer by intravenous injection of heparin.
    Schauer UJ; Schauer I; Rühling K; Thielmann K
    Biomed Biochim Acta; 1984; 43(10):1165-72. PubMed ID: 6525190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-hemostatic action of heparin: relationship between topical and intravenous application.
    Magalhàes JR; Unglert CV; Damiani H; Nogueira Filho J
    Acta Physiol Lat Am; 1971; 21(3):209-15. PubMed ID: 5158678
    [No Abstract]   [Full Text] [Related]  

  • 12. [Plasma concentration of heparin after subcutaneous injection at various sites].
    Gensini GF; Fortini A
    Clin Ter; 1981 May; 97(3):299-304. PubMed ID: 7285535
    [No Abstract]   [Full Text] [Related]  

  • 13. The monitoring of heparin administration by screening tests in experimental dogs.
    Mischke R; Jacobs C
    Res Vet Sci; 2001 Apr; 70(2):101-8. PubMed ID: 11356088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The heparin target organ--the endothelium. Studies in a rat model.
    Hiebert LM; Wice SM; McDuffie NM; Jaques LB
    Q J Med; 1993 May; 86(5):341-8. PubMed ID: 8327652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma heparin levels after administration of calcium and sodium salts of heparin.
    Thomas DP; Sagar S; Stamatakis JD; Maffei FH; Erdi A; Kakkar VV
    Thromb Res; 1976 Sep; 9(3):241-8. PubMed ID: 790636
    [No Abstract]   [Full Text] [Related]  

  • 16. The biodistribution of exogenous [35S]heparin in the dog.
    Schaefer C; Lo Bue J; Gollub S
    Proc Soc Exp Biol Med; 1980 May; 164(1):69-74. PubMed ID: 7375475
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacokinetic study of theophylline in dogs after intravenous administration with and without ethylenediamine.
    Kawai H; Kokubun S; Matsumoto T; Kojima J; Onodera K
    Methods Find Exp Clin Pharmacol; 2000 Apr; 22(3):179-84. PubMed ID: 10893702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-thrombotic effects of CX-397, a recombinant hirudin analog, in a canine model of coronary artery thrombosis.
    Ohyama T; Hori T; Moriike M; Asano T; Hayashi H; Iwade K; Hosoda S
    Thromb Haemost; 1998 Feb; 79(2):423-30. PubMed ID: 9493602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and pharmacodynamics of a low molecular weight heparin (enoxaparin) after subcutaneous injection, comparison with unfractionated heparin--a three way cross over study in human volunteers.
    Bendetowicz AV; Béguin S; Caplain H; Hemker HC
    Thromb Haemost; 1994 Mar; 71(3):305-13. PubMed ID: 8029794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The observation of heparin on endothelium after injection.
    Hiebert LM; Jaques LB
    Thromb Res; 1976 Feb; 8(2):195-204. PubMed ID: 1251350
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.